These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8463922)

  • 1. Single-dose pharmacokinetics of recombinant human erythropoietin in preterm infants after intravenous and subcutaneous administration.
    Brown MS; Jones MA; Ohls RK; Christensen RD
    J Pediatr; 1993 Apr; 122(4):655-7. PubMed ID: 8463922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of erythropoietin following single-dose subcutaneous administration in preterm infants.
    Krishnan R; Shankaran S; Krishnan M; Kauffman RE; Kumar P; Lucena J
    Biol Neonate; 1996; 70(3):135-40. PubMed ID: 8894079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary loss of erythropoietin after intravenous versus subcutaneous epoetin-beta in preterm infants.
    Langer J; Obladen M; Dame C
    J Pediatr; 2008 May; 152(5):728-30. PubMed ID: 18410782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weekly intravenous administration of recombinant human erythropoietin in infants with the anaemia of prematurity.
    Beck D; Masserey E; Meyer M; Calame A
    Eur J Pediatr; 1991 Sep; 150(11):767-72. PubMed ID: 1959538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics meta-analysis of recombinant human erythropoietin in healthy subjects.
    Olsson-Gisleskog P; Jacqmin P; Perez-Ruixo JJ
    Clin Pharmacokinet; 2007; 46(2):159-73. PubMed ID: 17253886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant erythropoietin in very-low-birth-weight infants.
    van den Anker JN; Montini G; Carnielli VP
    N Engl J Med; 1994 Sep; 331(10):677; author reply 677-8. PubMed ID: 8093178
    [No Abstract]   [Full Text] [Related]  

  • 7. Enteral administration of recombinant erythropoietin to preterm infants.
    Britton JR; Christensen RD
    J Perinatol; 1995; 15(4):281-3. PubMed ID: 8558334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary losses of recombinant erythropoietin in preterm infants.
    Bührer C; Obladen M; Maier R; Müller C
    J Pediatr; 2003 Apr; 142(4):452-3. PubMed ID: 12712072
    [No Abstract]   [Full Text] [Related]  

  • 9. Follow-up of very low birth weight infants after erythropoietin treatment to prevent anemia of prematurity.
    Soubasi V; Kremenopoulos G; Diamanti E; Tsantali C; Sarafidis K; Tsakiris D
    J Pediatr; 1995 Aug; 127(2):291-7. PubMed ID: 7636658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study.
    Meyer MP; Meyer JH; Commerford A; Hann FM; Sive AA; Moller G; Jacobs P; Malan AF
    Pediatrics; 1994 Jun; 93(6 Pt 1):918-23. PubMed ID: 8190577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-dose darbepoetin administration to anemic preterm neonates.
    Warwood TL; Ohls RK; Wiedmeier SE; Lambert DK; Jones C; Scoffield SH; Neeraj G; Veng-Pedersen P; Christensen RD
    J Perinatol; 2005 Nov; 25(11):725-30. PubMed ID: 16151471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human recombinant erythropoietin in the prevention and treatment of anemia of prematurity.
    Ohls RK
    Paediatr Drugs; 2002; 4(2):111-21. PubMed ID: 11888358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacokinetics of recombinant human erythropoietin after intravenous and subcutaneous administration to healthy subjects.
    Salmonson T; Danielson BG; Wikström B
    Br J Clin Pharmacol; 1990 Jun; 29(6):709-13. PubMed ID: 2378790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of treatment results for anemia of prematurity treated with various doses of human recombinant erythropoietin].
    Lauterbach R; Kachlik P; Pawlik D; Bajorek I
    Pediatr Pol; 1995 Sep; 70(9):739-44. PubMed ID: 8657506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of oral and intravenous iron supplementation in preterm infants receiving recombinant erythropoietin.
    Meyer MP; Haworth C; Meyer JH; Commerford A
    J Pediatr; 1996 Aug; 129(2):258-63. PubMed ID: 8765624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin therapy for anemia of prematurity.
    Merchant RH; Sonigara S; Sanghvi KP
    Indian Pediatr; 1996 Apr; 33(4):323-6. PubMed ID: 8772909
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of recombinant erythropoietin in treatment of the anemia of prematurity.
    Halpérin DS
    Am J Pediatr Hematol Oncol; 1991; 13(3):351-63. PubMed ID: 1793163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of protein intake on erythropoiesis during erythropoietin treatment of anemia of prematurity.
    Brown MS; Shapiro H
    J Pediatr; 1996 Apr; 128(4):512-7. PubMed ID: 8618185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human erythropoietin therapy for treatment of anemia of prematurity in very low birth weight infants: a randomized, double-blind, placebo-controlled trial.
    Kumar P; Shankaran S; Krishnan RG
    J Perinatol; 1998; 18(3):173-7. PubMed ID: 9659643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of short-term erythropoietin therapy in anemic premature infants.
    Reiter PD; Rosenberg AA; Valuck R; Novak K
    J Perinatol; 2005 Feb; 25(2):125-9. PubMed ID: 15526012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.